UHealth - University of Miami Health System

Summarizing surrogate markers for Alzheimer’s

Posted: 12.21.2010

Using surrogate markers to diagnose Alzheimer’s in young patients decades before the onset of dementia symptoms is a practice that has received considerable mainstream press. In the clip, UHealth’s Richard Isaacson, M.D., assistant professor of neurology and medicine, explains how these new markers will change the face of current therapy, speed drug development and could increase the number of disability claims filed in the United States.

E-mail a Friend


Connect with doctors & view medical records


Free on-line health risk assessments that may save your life.